Breaking News, Trials & Filings

Trials & Filings in Brief: Nov. 13, 2013

Discovery Labs, Fibrogen, Pluristem, RXi, Tekmira, Vivus, Zysis

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Preclinical Tekmira posts Ebola, Marburg delay-to-treatment results . . . read more Phase II Discovery Labs cleared to begin IIa/b Aerosurf trial . . . read more Fibrogen presents CKD-ESRD hemoglobin correction data . . . read more Pluristem cleared by MFDS for IC trial . . . read more RXi begins study in scar correction . . . read more Filings Vivus’ Qysmia receives two new patents . . . read more Zysis gets LAO Aripiprazole patent . . . read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters